Click here for Analysts' Upgrades, Downgrades.

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK (

TheStreet

) --

STOCK COMMENTS / EPS CHANGES

Campbell Soup

(CPB) - Get Report

estimates lowered through 2013 at Morgan Stanley. Lower promotional spending could hurt volume demand, Morgan Stanley said. Underweight rating and $32 price target.

Hormel Foods

(HRL) - Get Report

numbers raised at Goldman Sachs. Shares of HRL now seen reaching $50. Estimates also increased, to match the company's new guidance, Goldman said. Neutral rating.

Ameren

(AEE) - Get Report

was removed from the Conviction Sell list at Goldman Sachs. Company lacks negative near-term catalysts. $26 price target.

Altera's

(ALTR) - Get Report

price target was raised at UBS to $38.50. Company should be able to expand its margins in the coming quarters. Buy rating.

Eaton Vance's

(EV) - Get Report

numbers were boosted at Goldman Sachs. Shares are now seen reaching $29. Estimates also upped, given higher expected margins. Neutral rating.

Eaton Vance's price target was lifted at Barclays to $29. Company's attractive product lineup is well suited for rising interest rates, higher inflation and higher taxes, Barclays said. Maintain Equal Weight rating.

Fairchild Semiconductor

(FCS)

numbers boosted at Citigroup. Shares now seen reaching $21. Estimates also upped, given increased demand visibility. Buy rating.

FMC Technologies

(FTI) - Get Report

price target raised at Credit Suisse to $84 from $72 as competition fears abate. Maintain Neutral rating.

Guess

(GES) - Get Report

estimates, target boosted through 2011 at Jefferies. Company is leveraging its growth across the globe. Buy rating and new $60 price target.

Guess estimates boosted at Credit Suisse. EPS estimates for 2011 and 2012 are lifted to $3.04 and $3.50, respectively. Guess reported solid earnings Tuesday with strong margin growth ahead, Credit Suisse said. Maintain Outperform rating and $60 price target.

ICON plc

(ICLR) - Get Report

price target cut at Barclays to $26 from $28. Losses in the company's Central Lab could reoccur, Barclays said. Maintain Overweight rating.

LTX-Credence

(LTXC)

price target cut at Barclays by one dollar to $8 to reflect expectations for merger completion. Maintain Equal weight rating.

Medtronic

(MDT) - Get Report

estimates lowered at Goldman Sachs through 2013. Company is seeing lower demand across the board. Neutral rating and $36 price target.

Mead Johnson

(MJN)

estimates increased at Goldman Sachs through 2011. Sales could benefit from a recent competitor recall. Buy rating and $66 price target.

Micron

(MU) - Get Report

target raised at UBS to $7.50. Company could benefit from strong demand for new consumer products. Neutral rating.

Noble

(NE) - Get Report

added to Top Picks List at FBR Capital Markets. Company has a strong backlog, and the market over-reacted to the November rig report. New $45 price target.

National Oil Well Varco

(NOV) - Get Report

price target boosted at Barclays to $71 from $62given the strength and visibility of the offshore rig construction cycle, Barclays said. Maintain Overweight rating.

Overseas Shipholding

(OSG) - Get Report

added to Top Picks List at FBR Capital Markets. Company has a defensive pressure, as tanker rates are falling.

Stancorp Financial

(SFG)

estimates increased at Morgan Stanley through 2012. Company is leveraged to an economic recovery. Equal-weight rating.

This article was written by a staff member of TheStreet.